BMP2 inhibits cell proliferation by downregulating EZH2 in gastric cancer
暂无分享,去创建一个
[1] P. Yu,et al. Bone Morphogenetic Protein-2 Induces Non-Canonical Inflammatory and Oxidative Pathways in Human Retinal Endothelial Cells , 2021, Frontiers in Immunology.
[2] F. Jirik,et al. Is Use of BMP-2 Associated with Tumor Growth and Osteoblastic Differentiation in Murine Models of Osteosarcoma? , 2020, Clinical orthopaedics and related research.
[3] A. V. van Wijnen,et al. Combination of BMP2 and EZH2 inhibition to stimulate osteogenesis in a 3D bone reconstruction model. , 2020, Tissue engineering. Part A.
[4] Xiaobin Wu,et al. Exosome-Delivered LncHEIH Promotes Gastric Cancer Progression by Upregulating EZH2 and Stimulating Methylation of the GSDME Promoter , 2020, Frontiers in Cell and Developmental Biology.
[5] Weijian Guo,et al. EZH2: a novel target for cancer treatment , 2020, Journal of Hematology & Oncology.
[6] A. V. van Wijnen,et al. Inhibition of the epigenetic suppressor EZH2 primes osteogenic differentiation mediated by BMP2 , 2020, The Journal of Biological Chemistry.
[7] H. El‐Serag,et al. Burden of Gastric Cancer. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[8] Yongchun Zhang,et al. BMP Signaling in Development, Stem Cells, and Diseases of the Gastrointestinal Tract. , 2020, Annual review of physiology.
[9] Siyu Yang,et al. The role and prospect of JMJD3 in stem cells and cancer. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[10] S. Luo,et al. Effects of microRNA-378 on epithelial-mesenchymal transition, migration, invasion and prognosis in gastric carcinoma by targeting BMP2. , 2019, European review for medical and pharmacological sciences.
[11] E. Alsberg,et al. Combinatorial morphogenetic and mechanical cues to mimic bone development for defect repair , 2019, Science Advances.
[12] Jianbao Zheng,et al. Bile acids promote gastric intestinal metaplasia by upregulating CDX2 and MUC2 expression via the FXR/NF-κB signalling pathway , 2019, International journal of oncology.
[13] Prashanth Rawla,et al. Epidemiology of gastric cancer: global trends, risk factors and prevention , 2018, Przeglad gastroenterologiczny.
[14] A. Jemal,et al. Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.
[15] Ling Yan,et al. Evaluation of the effects of the combination of BMP-2-modified BMSCs and PRP on cartilage defects , 2018, Experimental and therapeutic medicine.
[16] Qian Li,et al. Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential , 2018, Biomarker Research.
[17] Midie Xu,et al. The polycomb group protein EZH2 induces epithelial–mesenchymal transition and pluripotent phenotype of gastric cancer cells by binding to PTEN promoter , 2018, Journal of Hematology & Oncology.
[18] J. Sen,et al. Perturbation of canonical and non-canonical BMP signaling affects migration, polarity and dendritogenesis of mouse cortical neurons , 2018, Development.
[19] Jeffrey C. Wang,et al. Bone morphogenetic protein-2 and tumor growth: Diverse effects and possibilities for therapy. , 2017, Cytokine & growth factor reviews.
[20] Byung-Hyun Park,et al. Recombinant human bone morphogenetic protein-2 inhibits gastric cancer cell proliferation by inactivating Wnt signaling pathway via c-Myc with aurora kinases , 2016, Oncotarget.
[21] Baolin Wang,et al. BMP regulates regional gene expression in the dorsal otocyst through canonical and non-canonical intracellular pathways , 2016, Development.
[22] Samuel K. Cho,et al. Association Between BMP-2 and Carcinogenicity , 2015, Spine.
[23] Yoon Young Choi,et al. Evolution of Gastric Cancer Treatment: From the Golden Age of Surgery to an Era of Precision Medicine , 2015, Yonsei medical journal.
[24] Jianping Zhang,et al. C23 protein meditates bone morphogenetic protein-2-mediated EMT via up-regulation of Erk1/2 and Akt in gastric cancer , 2015, Medical Oncology.
[25] Dawei Sun,et al. RETRACTED ARTICLE: Bone morphogenetic protein 2 mediates epithelial-mesenchymal transition via AKT and ERK signaling pathways in gastric cancer , 2015, Tumor Biology.
[26] E. Hurwitz,et al. Cancer risk after use of recombinant bone morphogenetic protein-2 for spinal arthrodesis. , 2013, The Journal of bone and joint surgery. American volume.
[27] Zhirong Wang,et al. Effect of Bone Morphogenetic Protein-2 on Proliferation and Apoptosis of Gastric Cancer Cells , 2012, International journal of medical sciences.
[28] K. Miyazono,et al. Bone morphogenetic protein-2 and -4 play tumor suppressive roles in human diffuse-type gastric carcinoma. , 2011, The American journal of pathology.
[29] H. Aburatani,et al. Activation of Bmp2-Smad1 Signal and Its Regulation by Coordinated Alteration of H3K27 Trimethylation in Ras-Induced Senescence , 2011, PLoS genetics.
[30] Jung lim Kim,et al. Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-κB pathway, and MMP-9 expression. , 2011, Experimental cell research.
[31] Guy Sauvageau,et al. Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer. , 2010, Cell stem cell.
[32] A. Hoffmann,et al. Enhancement of endoprosthesis anchoring using BMP-2. , 2010, Technology and health care : official journal of the European Society for Engineering and Medicine.
[33] K. Helin,et al. Polycomb group protein-mediated repression of transcription. , 2010, Trends in biochemical sciences.
[34] S. Oh,et al. BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway. , 2010, Experimental cell research.
[35] S. Oh,et al. The Bone Morphogenesis Protein-2 (BMP-2) is associated with progression to metastatic disease in gastric cancer. , 2008, Cancer research and treatment : official journal of Korean Cancer Association.
[36] S. Baylin,et al. Frequent epigenetic silencing of the bone morphogenetic protein 2 gene through methylation in gastric carcinomas , 2006, Oncogene.
[37] Y. Yuasa,et al. BMP-2 modulates the proliferation and differentiation of normal and cancerous gastric cells. , 2004, Biochemical and biophysical research communications.
[38] J. Keller,et al. Bone morphogenetic protein 2 is expressed by, and acts upon, mature epithelial cells in the colon. , 2003, Gastroenterology.
[39] Jun Ho Jeon,et al. Aberrant signaling of TGF-beta1 by the mutant Smad4 in gastric cancer cells. , 2003, Cancer letters.
[40] H. Iba,et al. Application of efficient and specific gene transfer systems and organ culture techniques for the elucidation of mechanisms of epithelial– mesenchymal interaction in the developing gut , 2000, Development, growth & differentiation.
[41] H. Espejo,et al. [Gastric cancer]. , 1996, Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru.
[42] V. Rosen,et al. Novel regulators of bone formation: molecular clones and activities. , 1988, Science.
[43] M. Urist,et al. Solubilized and insolubilized bone morphogenetic protein. , 1979, Proceedings of the National Academy of Sciences of the United States of America.